Guidelines for Anticoagulation Therapy for Secondary Prevention After Deep Vein Thrombosis
Residual Vein Thrombosis (RVT) to Determine Duration of Anticoagulation6
June 2011
The way they defined residual thrombus was by compression ultrasonography. When they compressed the involved venous segment, if the diameter of the vein was more than 40 percent of the uncompressed venous diameter, this met criteria for residual venous thrombosis. On the other hand, if the thrombus by compression was less than 40 percent of the original vein diameter, then this was consistent with the definition of thrombus resolution.
RVT to Determine Anticoagulation6 |
Jump to section:
- Introduction
- Independent Risk Factors for Venous Thromboembolism1
- Thrombophilia Testing
- ACCP Treatment Duration Guidelines2
- Aggressive Thrombophilia2
- Case
- Case
- Recurrence Rate
- ACCP Treatment Duration Guidelines3
- D-Dimer Levels and Risk of Recurrent Venous Thromboembolism4
- PROLONG: D-Dimer Testing to Determine Duration of Anticoagulation5
- PROLONG: D-Dimer Testing to Determine Duration of Anticoagulation5
- Idiopathic VTE
- Residual Vein Thrombosis (RVT) to Assess Optimal Management of DVT: DACUS Study6
- Residual Vein Thrombosis (RVT) to Determine Duration of Anticoagulation6
- Recurrent VTE by RVT at 3 Months: DACUS Study6
- Non-compressed vs. Compressed
- Idiopathic DVT: Take Home Point
- Case (revisited)
- Case (revisited)
- Mortality Risk
- Cumulative Recurrence of DVT vs PE After Incident DVT
- Cumulative Recurrence of DVT vs PE After Incident PE
- Independent Predictors of Death within 7 Days of Venous Thromboembolism Recurrence
- Idiopathic PE – Take Home Points
- References
- Clinical and Laboratory Update in Thrombosis and Anticoagulation
- Questions?
External
link
PDF
document
Excel
document
Word
document